Planning Center Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$672K Hold
560
0.06% 45
2026
Q1
$515K Hold
560
0.05% 46
2025
Q4
$602K Hold
560
0.06% 44
2025
Q3
$427K Hold
560
0.04% 49
2025
Q2
$437K Hold
560
0.05% 46
2025
Q1
$463K Hold
560
0.05% 46
2024
Q4
$432K Hold
560
0.05% 43
2024
Q3
$496K Hold
560
0.06% 40
2024
Q2
$507K Hold
560
0.07% 39
2024
Q1
$436K Hold
560
0.09% 39
2023
Q4
$326K Sell
560
-2
-0.4% -$1.17K 0.08% 44
2023
Q3
$302K Hold
562
0.08% 46
2023
Q2
$264K Sell
562
-181
-24% -$75.9K 0.07% 54
2023
Q1
$279K Hold
743
0.08% 48
2022
Q4
$272K Buy
+743
New +$263K 0.08% 55

Other funds holding LLY

Planning Center Inc's LLY Position: Q2 2026 in Review

Planning Center Inc held its Eli Lilly (LLY) position steady in Q2 2026 at 560 shares worth $672K. The position accounts for 0.06% of the portfolio, ranked #45.

Planning Center Inc first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Planning Center Inc held 560 shares of Eli Lilly worth $672K as of Q2 2026.
  • Planning Center Inc left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.06% of Planning Center Inc's portfolio in Q2 2026, its #45 holding.
  • Planning Center Inc first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Planning Center Inc's 13F filing for Q2 2026, filed 30 Jul 2026.